Overview: The WATCHMAN procedure is a minimally invasive treatment option designed to reduce the risk of stroke in patients with atrial fibrillation (AFib) who are not suitable candidates for long-term anticoagulant therapy, commonly due to bleeding, falls, or cost issues. This procedure involves implanting a device into the heart’s left atrial appendage (LAA) to prevent blood clots from forming and entering the bloodstream, which can lead to a stroke. This is a therefore a type of left atrial appendage occlusion implant.

What is the WATCHMAN Device?

• The WATCHMAN device is a small, umbrella-shaped implant made from a combination of nitinol and fabric. It is designed to fit securely within the LAA, a small pouch in the left atrium where blood clots tend to form in patients with AFib.

Procedure Details:

1. Preparation:
   • Patients undergo a thorough evaluation, including imaging studies like a transesophageal echocardiogram (TEE) and CT scan, to ensure the LAA is suitable for the WATCHMAN device.
   • Patients may need to stop certain medications before the procedure but will need to tolerate a short period of blood thinners.
2. During the Procedure:
   • Performed under general anesthesia, the procedure typically takes about an hour.
   • A large IV is inserted into the vein in the groin area, through which a catheter is advanced to the heart.
   • Using fluoroscopic and echocardiographic guidance, the WATCHMAN device is delivered to the LAA through the catheter.
   • The device is expanded to fit snugly and securely within the LAA, effectively sealing it off.
   • The catheter is then removed, and the IV is removed.
3. Recovery:
   • Patients are monitored overnight in the hospital and can go home the next day.
   • Follow-up appointments are scheduled to monitor the device’s position and the heart’s healing process.
   • Patients will need to take blood thinning medication for a short period post-procedure until the device is fully integrated into the heart tissue.

Benefits of the WATCHMAN Procedure:

• Stroke Risk Reduction: Significantly lowers the risk of stroke in patients with non-valvular AFib.
• Alternative to Anticoagulants: Provides a viable option for patients who are unable to take blood thinners long-term due to bleeding risks or other issues.
• Minimally Invasive: Less invasive than open-heart surgery, leading to quicker recovery and fewer complications.
• Long-Term Solution: Once integrated, the device offers a permanent solution to reducing stroke risk.

Risks and Considerations:

• Potential Complications: Include bleeding, infection, device-related issues, or embolization. However, these risks are generally low.
• Follow-Up Care: Essential to ensure the device is functioning properly and sealing the LAA well. Regular check-ups and imaging studies are required.

Why Choose Us:

Our WATCHMAN team at Cardiac Specialists including Drs. Robert Winslow, Murali Chiravuri, Bryan Lawlor, Ari Pollack, Matthew Seigerman and Chirag Shah specialize in advanced treatments for atrial fibrillation, including the WATCHMAN procedure. We offer comprehensive pre-procedure evaluations, expert implantation, and dedicated post-procedure care to ensure the best outcomes for our patients. Our commitment to patient education and support helps you make informed decisions about your heart health.

For more information on the WATCHMAN procedure or to schedule a consultation, please contact us.